The molecular signatures database hallmark gene set collection A Liberzon, C Birger, H Thorvaldsdóttir, M Ghandi, JP Mesirov, P Tamayo Cell systems 1 (6), 417-425, 2015 | 7676 | 2015 |
Next-generation characterization of the cancer cell line encyclopedia M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ... Nature 569 (7757), 503-508, 2019 | 2196 | 2019 |
Defining a cancer dependency map A Tsherniak, F Vazquez, PG Montgomery, BA Weir, G Kryukov, ... Cell 170 (3), 564-576. e16, 2017 | 1880 | 2017 |
Punctuated evolution of prostate cancer genomes SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ... Cell 153 (3), 666-677, 2013 | 1360 | 2013 |
Genetic and transcriptional evolution alters cancer cell line drug response U Ben-David, B Siranosian, G Ha, H Tang, Y Oren, K Hinohara, ... Nature 560 (7718), 325-330, 2018 | 785 | 2018 |
Quantitative proteomics of the cancer cell line encyclopedia DP Nusinow, J Szpyt, M Ghandi, CM Rose, ER McDonald III, M Kalocsay, ... Cell 180 (2), 387-402. e16, 2020 | 606 | 2020 |
Enhanced Regulatory Sequence Prediction Using Gapped k-mer Features M Ghandi, D Lee, M Mohammad-Noori, MA Beer PLoS computational biology 10 (7), e1003711, 2014 | 497 | 2014 |
ARID1B is a specific vulnerability in ARID1A-mutant cancers KC Helming, X Wang, BG Wilson, F Vazquez, JR Haswell, HE Manchester, ... Nature medicine 20 (3), 251-254, 2014 | 401 | 2014 |
Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia DA Landau, K Clement, MJ Ziller, P Boyle, J Fan, H Gu, K Stevenson, ... Cancer cell 26 (6), 813-825, 2014 | 365 | 2014 |
The landscape of cancer cell line metabolism H Li, S Ning, M Ghandi, GV Kryukov, S Gopal, A Deik, A Souza, K Pierce, ... Nature medicine 25 (5), 850-860, 2019 | 361 | 2019 |
Pharmacogenomic agreement between two cancer cell line data sets CCLE Consortium, GDSC Consortium Nature 528 (7580), 84-87, 2015 | 340* | 2015 |
WRN helicase is a synthetic lethal target in microsatellite unstable cancers EM Chan, T Shibue, JM McFarland, B Gaeta, M Ghandi, N Dumont, ... Nature 568 (7753), 551-556, 2019 | 262 | 2019 |
Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs K Hadi, X Yao, JM Behr, A Deshpande, C Xanthopoulakis, H Tian, ... Cell 183 (1), 197-210. e32, 2020 | 149 | 2020 |
gkmSVM: an R package for gapped-kmer SVM M Ghandi, M Mohammad-Noori, N Ghareghani, D Lee, L Garraway, ... Bioinformatics 32 (14), 2205-2207, 2016 | 148 | 2016 |
Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations A Louissaint Jr, KT Schafernak, JT Geyer, AE Kovach, M Ghandi, ... Blood, The Journal of the American Society of Hematology 128 (8), 1093-1100, 2016 | 140 | 2016 |
ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors EM Goetz, M Ghandi, DJ Treacy, N Wagle, LA Garraway Cancer research 74 (23), 7079-7089, 2014 | 131 | 2014 |
Systematic functional characterization of resistance to PI3K inhibition in breast cancer X Le, R Antony, P Razavi, DJ Treacy, F Luo, M Ghandi, P Castel, ... Cancer discovery 6 (10), 1134-1147, 2016 | 118 | 2016 |
The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst 1: 417–425 A Liberzon, C Birger, H Thorvaldsdottir, M Ghandi, JP Mesirov, P Tamayo | 101 | 2015 |
The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015; 1: 417–25 A Liberzon, C Birger, H Thorvaldsdóttir, M Ghandi, JP Mesirov, P Tamayo | 99 | |
Characterizing genomic alterations in cancer by complementary functional associations JW Kim, OB Botvinnik, O Abudayyeh, C Birger, J Rosenbluh, Y Shrestha, ... Nature biotechnology 34 (5), 539-546, 2016 | 98 | 2016 |